An Introduction to the Contradictions Between
Medical Science and Immunization Policy

by Alan Phillips, Director
Citizens for Healthcare Freedom

References (Page 1, Page 2, Page 3)

1. Vaccine Adverse Events Reporting System (VAERS); National Technical Information Service, Springfield, VA 22161, 703-487-4650, 703-487-4600; see also NVIC, infra note 7; and the VAERS website at http://www.fda.gov/cber/vaers/vaers.htm.
2. Statement of the National Vaccine Information Center (NVIC), Hearing of the House Subcommittee on Criminal Justice, Drug Policy and Human Resources, "Compensating Vaccine Injuries: Are Reforms Needed?" September 28, 1999.
3. Less than 1%, according to Barbara Fisher, citing former FDA Commissioner David Kessler, 1993, JAMA, in the Statement of the NVIC, supra note 2.
4. Less than 10%, according to KM Severyn, R.Ph., Ph.D. in the Dayton Daily News, May 28, 1993. (Vaccine Policy Institute, 251 Ridgeway Dr., Dayton, OH 45459)
5. American Association of Physicians and Surgeons, Fact Sheet on Mandatory Vaccines at http://www.aapsonline.org/.
6. Jane Orient, M.D., Director of the American Association of Physicians and Surgeons, "Mandating Vaccines: Government Practicing Medicine Without a License?" 1999.
7. National Vaccine Information Center (NVIC), 512 Maple Ave. W. #206, Vienna, VA 22180, 703-938-0342; "Investigative Report on the Vaccine Adverse Event Reporting System."
8. 42 U.S.C.S. § 300aa-25(b)(1)(A),(B).
9. Karlsson L. Scheibner V. Association between non-specific stress syndrome, DPT injections and cot death. Paper presented to the 2nd immunization conference, Canberra, Australia, May 27-29, 1992. See also Viera Schiebner, Ph.D., Vaccination: 100 Years of Orthodox Research Shows that Vaccines Represent a Medical Assault on the Immune System for discussion and references.
10. W.C. Torch, "Diptheria-pertussis-tetanus (DPT) immunization: A potential cause of the sudden infant death syndrome (SIDS)," (Amer. Academy of Neurology, 34th Annual Meeting, Apr 25 - May 1, 1982), Neurology 32(4), pt. 2.
11. Id.
12. Viera Schiebner, Ph.D., Vaccination: 100 Years of Orthodox Research Shows that Vaccines Represent a Medical Assault on the Immune System, 1993.
13. Confounding in studies of adverse reactions to vaccines [see comments]. Fine PE, Chen RT, REVIEW ARTICLE: 38 REFS. Comment in: Am J Epidemiol 1994 Jan 15;139(2):229-30. Division of Immunization, Centers for Disease Control, Atlanta, GA 30333.
14. See Viera Scheibner, supra note 12.
15. Nature and Rates of Adverse Reactions Associated with DTP and DT Immunizations in Infants and Children (Pediatrics, Nov. 1981, Vol. 68, No. 5
16. DPT Report, The Fresno Bee, Community Relations, 1626 E. Street, Fresno, CA 93786, December 5, 1984.
17. Trollfors B, Rabo, E. 1981. Whooping cough in adults. British Medical Journal (September 12), 696-97.
18. National Vaccine Injury Compensation Program (NVICP) http://bhpr.hrsa.gov/vicp/.
19. Measles vaccine failures: lack of sustained measles specific immunoglobulin G responses in revaccinated adolescents and young adults. Department of Pediatrics, Georgetown University Medical Center, Washington, DC 20007. Pediatric Infectious Disease Journal. 13(1):34-8, 1994 Jan.
20. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy. Department of Preventive Medicine and Biostatistics, University of Toronto, Ont. Canadian Medical Association Journal. 150(7):1093-8, 1994 APR 1.
21. Haemophilus b disease after vaccination with Haemophilus b polysaccharide or conjugate vaccine. Institution Division of Bacterial Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Md 20892. American Journal of Diseases of Children. 145(12):1379-82, 1991 Dec.
22. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. Division of Field Epidemiology, Centers for Disease Control and Prevention, Atlanta, Georgia. Journal of Infectious Diseases. 169(1):77-82, 1994 Jan. 1.
23. Secondary measles vaccine failure in healthcare workers exposed to infected patients. Department of Pediatrics, Children's Hospital of Philadelphia, PA 19104. Infection Control & Hospital Epidemiology. 14(2):81-6, 1993 Feb.
24. MMWR (Morbidity and Mortality Weekly Report) 38 (8-9), 12/29/89.
25. MMWR "Measles." 1989; 38:329-330.
26. MMWR. 33(24),6/22/84.
27. Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons. Review article: 50 REFS. Dept. of Internal Medicine, Mayo Vaccine Research Group, Mayo Clinic and Foundation, Rochester, MN. Archives of Internal Medicine. 154(16):1815-20, 1994 Aug 22.
28. Clinical Immunology and Immunopathology, May 1996; 79(2): 163-170.
29. Trevor Gunn, Mass Immunization, A Point in Question, at 15 (citing E.D. Hume, Pasteur Exposed-The False Foundations of Modern Medicine, Bookreal, Australia, 1989.)
30. Physician William Howard Hay's address of June 25, 1937; printed in the Congressional Record.
31. Eleanor McBean, The Poisoned Needle, Health Research, 1956.
32. Outbreak of paralytic poliomyelitis in Oman; evidence for widespread transmission among fully vaccinated children. Lancet vol 338: Sept 21, 1991; 715-720.
33. Neil Miller, Vaccines: Are They Really Safe and Effective? Fifth Printing, 1994, at 33.
34. Chicago Dept. of Health.
35. Harold Buttram, M.D., "Vaccine Scene 2000, Review and Update," Medical Sentinel, Vol.5 No. 2, March/April 2000.
36. Neil Miller, supra note 33 at 45 [NVIC News, April 92 at 12].
37. S. Curtis, A Handbook of Homeopathic Alternatives to Immunization.
38. Darrell Huff, How to Lie With Statistics, W.W. Norton & Co., Inc., 1954 at 84.
39. Quoted from the internet, credited to Keith Block, M.D., a family physician from Evanston, Illinois, who has spent years collecting data in the medical literature on immunizations.
40. See Trevor Gunn, supra, note 29, at 15.
41. Id. at 21.
42. Id. at 21 (British Medical Council Publication 272, May 1950).
43. See Trevor Gunn, supra, note 29, at 21; see also Neil Miller, supra note 33 at 47 (Buttram, MD, Hoffman, Mothering Magazine, Winter 1985 at 30; Kalokerinos and Dettman, MDs, "The Dangers of Immunization," Biological Research Inst. [Australia], 1979, at 49).
44. See Mayo Vaccine Research Group, supra note 27.
45. See Neil Miller, supra note 33 at 34.
46. Chairman/Congressman Dan Burton, Committee of Government Reform, Opening Statement, "FACA: Conflicts of Interest and Vaccine Development, Preserving the Integrity of the Process," June 2000.
47. Archie Kalolerinos, MD, Every Second Child, Keats Publishing, Inc. 1981.
48. Washington Post, February 22, 1995.
49. Reported by KM Severyn, R.Ph, Ph.D. in the Dayton Daily News, June 3, 1995.
50. Vaccine Information and Awareness (VIA), "Measles and Antibody Titre Levels," from Vaccine Weekly, January 1996.
51. NVIC Press Release, "Consumer Group Warns use of New Chicken Pox Vaccine in all Healthy Children May Cause More Serious Disease".
52. Id. [Reported by KM Severyn, R.Ph., Ph.D.]
53. Hearings before the Committee on Interstate and Foreign Commerce, House of Representatives, 87th Congress, Second Session on H.R. 10541, May 1962, at 94.
54. NVIC Vaccine Conference Program Guide, 1997.
55. Unanimous resolution of the AAPS, 57th Annual Meeting, St. Louis, MO, October, 2000; see http://www.aapsonline.org/.
56. British Medical Journal, 1999, 318:193, 16 (January).
57. Singh V, Yang V. Serological association of measles virus and human herpes virus-6 with brain autoantibodies in autism. Clinical Immunology and Immunopathology 1998;88(l):105-108.
58. Wakefield AJ, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-641.
59. Wakefield AJ, Anthony A, Murch SH, Thomson M, Montgomery SM, et al. Enterocolitis in Children With Developmental Disorders. Am J Gastroenterol September; 95:2285-2295.
60. Stephanie Cave, MD, NVIC Vaccine Conference, September, 2000; see http://www.909shot.com for conference transcripts and information.
61. Congressman Dan Burton, House Committee on Government Reform, Hearing on Mercury and Medicine, 6/18/2000.
62. Press Release, Feb. 12, 2001; see http://www.autism.com/ari/press1.html
63. Dana Ullman, Discovering Homeopathy, at 42 (Thomas L. Bradford, Logic Figures, p68, 113-146; Coulter, Divided Legacy, Vol 3, p268).
64. See S. Curtis, supra note 34.
65. See S. Curtis, supra note 34.
66. Isaac Golden, Vaccination? A Review of Risks and Alternatives, 5th Edition, 1994. (Australia).
67. Allanson v. Clinton Central School District, No. CV 84-174, slip op. at 5 (N.D.N.Y. 1984).
68. Sherr and Levy vs. Northport East-Northport Union Free School District, 672 F. Supp. 81 (E.D.N.Y. 1987).
69. Fishkin v. Yonkers Public Schools, 710 F. Supp. 506 (S.D.N.Y. 1989).
70. Berg v. Glen Cove City School District, 853 F. Supp. 651 (E.D.N.Y. 1994).
71. Congressman Dan Burton, Committee on Government Reform, "FACA: Conflicts of Interest and Vaccine Development: Preserving the Integrity of the Process," June 15, 2000.
72. "AAPS Resolution Concerning Mandatory Vaccines" at http://www.aapsonline.org/aaps/.
73. J. Barthelow Classen, M.D., M.B.A., President and CEO, Classen Immunotherapies, Inc., 6517 Montrose Ave, Baltimore, MD 21212
    Tel: (410) 377-4549 Fax: (410) 377-8526
    E-mail: Classen@vaccines.net, letter to The Honorable Dan Burton, Chairman U.S. House of Representatives, Committee on Government Reform, Washington, DC 20515, October 12th, 1999, at www.vaccines.net.
74. "Show us the Science," Mothering Magazine, March/April 2001, Report on the Sept. 2000 NVIC Vaccine Conference.
75. See J. Barthelow Classen, MD, MBA, supra note 73.
76. Viera Scheibner, PhD, 178 Govetts Leap Road, Blackheath, NSW 2785, Australia; phone +61 (0)2 4787 8203, Fax +61 (0)2 4787 8988
77. See J. Barthelow Classen, MD, MBA, supra note 73.
78. Statement of the National Vaccine Information Center, Hearing of the House Subcommittee on Criminal Justice, Drug Policy and Human Resources, "Compensating Vaccine Injuries: Are Reforms Needed?" September 28, 1999

Last Revision: May 2001

Return to Table of Contents #247